VKH
NXTM

Virtu KCG Holdings’s NxStage Medical Inc. NXTM Stock Holding History

Virtu KCG Holdings’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,903
Closed -$293K – 3788
2017
Q1 		$293K Buy
+10,903
New +$301K 0.01% 1978
2015
Q3 		– Sell
-15,796
Closed -$226K – 4050
2015
Q2 		$226K Buy
+15,796
New +$268K ﹤0.01% 2435

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Virtu KCG Holdings's NXTM Position: Q2 2017 in Review

Virtu KCG Holdings sold out of NxStage Medical Inc. (NXTM) in Q2 2017, closing a stake of 10,903 shares — an estimated $293K sold.

Virtu KCG Holdings first reported a position in NXTM in Q2 2015 and held it in 2 quarters. The position peaked at $293K in Q1 2017. 163 funds tracked by Wall St. Rank hold NXTM as of Q2 2017.

  • Virtu KCG Holdings reported no remaining NxStage Medical Inc. position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 10,903 NxStage Medical Inc. shares in Q2 2017, an estimated $293K.
  • Virtu KCG Holdings first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 2 quarters.
  • Virtu KCG Holdings's NxStage Medical Inc. position peaked at $293K in Q1 2017.
  • 163 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.